The Cannabis Industry’s Next Growth Markets Are Taking Shape
Marijuana stocks could soon see a big jump in overall momentum in the near future. Most of this is based on the growth and expansion of certain public companies. In 2026, we are soon to see the official start of cannabis being rescheduled to class 3. This will most likely come with an uphill battle at first. But there is a lot in the works and much to be done for future investing and trading to show sustainable patterns. Right now, the cannabis sector for marijuana stocks is still filled with a large amount of volatility. This volatility has given some investors the chance to find top marijuana stocks to buy at lower-than-normal prices.
With this current market action, 2027 can be one of the years of possible big profits for those who invest in top cannabis stocks now. Preparation is key and a true fundamental step in preparing for how you will invest and trade in the cannabis space. The more you know and the better steps you take to learn the sector and about the companies, the better your chances of taking strong profits. Marijuana stocks now represent more than dispensary chains and cultivation businesses.
Legal dispensaries are becoming part of a cannabis industry that includes pharmaceutical research. Not just that, but also commercial real estate, private credit, technology, packaging, and consumer brands. This expanding ecosystem gives public-market investors several ways to follow legal cannabis without relying on retail operators. The future of legal cannabis is happening right now, and most investors are here for it. Below are several top marijuana stocks to watch in the sector today.
Top Marijuana Stock Picks For Investors Now
Ascend Wellness Holdings (OTC:AAWH)
Trulieve Cannabis Corp. (NYSE:TRLV)
Cresco Labs Inc. (OTC:CRLBF)
Ascend Wellness Holdings
Ascend Wellness Holdings is a vertically integrated multistate cannabis operator serving Illinois, Maryland, Massachusetts, Michigan, New Jersey, Ohio, and Pennsylvania. It cultivates cannabis, manufactures products, supplies wholesale customers, and operates dispensaries.
Ascend’s newest development is its October 6 opening announcement for a Lewis Center, Ohio dispensary, which began serving medical patients and adult-use customers before its October 9 grand-opening event. The store raised Ascend’s Ohio footprint to seven dispensaries, adding another outlet for its in-house Ozone Reserve and Simply Herb products.
The opening builds on improving second-quarter results reported in August. Ascend generated $126.1 million in net revenue, up 7.9% sequentially, while retail revenue increased 11.5% to $92.7 million. Adjusted EBITDA reached $29.1 million, operating cash flow totaled $22.5 million, and free cash flow was $19.5 million. The company still reported a $9.8 million net loss and carried approximately $251.8 million in net debt.
Trulieve Cannabis Corp.
Trulieve Cannabis Corp. is a major U.S. medical cannabis operator headquartered in Florida. The company cultivates and manufactures cannabis products and distributes them through an extensive dispensary network. Trulieve’s latest major update remains its second-quarter report released August 7. This reflected the company’s transformation by federal medical-cannabis reform and its move to the New York Stock Exchange. The quarter included Trulieve and Harvest operations until Harvest was deconsolidated on June 3.
Trulieve reported $271 million in revenue, with retail producing 94% of sales, and achieved a 60% gross margin. Operating cash flow reached $53 million, free cash flow totaled $32 million, and quarter-end cash stood at $325 million. Its $406 million GAAP net loss was largely connected to a $407 million impact. This was from the harvest deconsolidation and related investment; adjusted net income was $20 million.
[Read More] Cannabis Stocks Enter A New Moment Of Financial Discipline
The company also began shipping medical cannabis products to licensed independent pharmacies in Georgia, opened four Florida dispensaries, and applied to register qualifying medical operations with the DEA.
Cresco Labs Inc.
Cresco Labs is a vertically integrated multistate cannabis company that cultivates, manufactures, and distributes branded products while operating Sunnyside dispensaries. Its consumer portfolio includes Cresco, High Supply, FloraCal, Good News, Mindy’s, Remedi and Wonder Wellness products. The most recent investor-facing development came on September 24.
At this time, it outlined proposals intended to prepare the company for a potential senior U.S. exchange listing. Shareholders are scheduled to vote October 30 on creating a new parent company, redomiciling that entity from British Columbia to Delaware and extending the sunset period for Cresco’s multiple-voting shares. The plan may also permit a reverse stock split if needed to satisfy listing requirements.
[Read More] Marijuana Stocks And The Cannabis Industry: What Investors Should Watch
This capital-markets initiative follows Cresco’s September 2 acquisition of nine operating Pennsylvania medical dispensaries from PharmaCann for $50 million. Pennsylvania produced more than $1.1 billion in medical cannabis sales during the previous year, making the transaction strategically important for Cresco’s retail and wholesale network.
The post Marijuana Stocks Expand Beyond Traditional Cannabis Companies appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™ .
